Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Research from G. Hess and co-researchers yields new findings on cancer
May 12th, 2008
According to a study from the United States, "Previous labeling and guidelines recommended initiating erythropoiesis agents (ESAs) for chemotherapy-induced anemia (CIA) at hemoglobin (Hb) levels < 11 g/dL, maintaining near 12 g/dL, and withholding at >= 13 g/dL. This study analyzed adherence with recommendations in administration of darbepoetin (CA) to cancer patients." "setting, and participants: Retrospective analysis of Hb levels at which CA was administered using Varian electronic medical records (EMRs). The dataset comprises 141694 cancer patients from 82 sites across 13 states. The study evaluated DA administrations with respect to recorded Hb for 8988 patients...
Source: Hematology Week (2008-05-12)
|
